DE69833160D1 - Amplifizierung und Detektion von HIV-1 und/oder HIV-2 - Google Patents

Amplifizierung und Detektion von HIV-1 und/oder HIV-2

Info

Publication number
DE69833160D1
DE69833160D1 DE69833160T DE69833160T DE69833160D1 DE 69833160 D1 DE69833160 D1 DE 69833160D1 DE 69833160 T DE69833160 T DE 69833160T DE 69833160 T DE69833160 T DE 69833160T DE 69833160 D1 DE69833160 D1 DE 69833160D1
Authority
DE
Germany
Prior art keywords
hiv
amplification
detection
subtypes
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69833160T
Other languages
English (en)
Other versions
DE69833160T2 (de
Inventor
John Wesley Backus
Susan Melissa Atwood
Ann Elizabeth Casey
Eric Brice Rasmussen
Thomas Joseph Cummins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of DE69833160D1 publication Critical patent/DE69833160D1/de
Application granted granted Critical
Publication of DE69833160T2 publication Critical patent/DE69833160T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69833160T 1997-06-25 1998-06-24 Amplifizierung und Detektion von HIV-1 und/oder HIV-2 Expired - Lifetime DE69833160T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5075997P 1997-06-25 1997-06-25
US50759P 1997-06-25

Publications (2)

Publication Number Publication Date
DE69833160D1 true DE69833160D1 (de) 2006-04-06
DE69833160T2 DE69833160T2 (de) 2006-09-14

Family

ID=21967243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69833160T Expired - Lifetime DE69833160T2 (de) 1997-06-25 1998-06-24 Amplifizierung und Detektion von HIV-1 und/oder HIV-2

Country Status (8)

Country Link
US (1) US6001558A (de)
EP (1) EP0887427B1 (de)
JP (1) JP4339427B2 (de)
AT (1) ATE315667T1 (de)
DE (1) DE69833160T2 (de)
DK (1) DK0887427T3 (de)
ES (1) ES2256920T3 (de)
SI (1) SI0887427T1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE282720T1 (de) * 1997-08-08 2004-12-15 Biomerieux Bv Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
DE19850186A1 (de) * 1998-10-30 2000-05-25 Roche Diagnostics Gmbh Neue Primer und Sonden zum Nachweis von HIV
FR2786786A1 (fr) * 1998-12-07 2000-06-09 Microdiag Procede et kit pour l'amplification, la detection et/ou la quantification de populations de genomes
US6303293B1 (en) * 1999-02-02 2001-10-16 Ortho-Clinical Diagnostics, Inc. Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof
WO2000046403A2 (en) * 1999-02-03 2000-08-10 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OFHEALT H AND HUMAN SERVICES Methods and reagents for molecular detection of hiv-1 groups m, n and o
US6623919B1 (en) * 1999-02-03 2003-09-23 Ortho-Clinical Diagnostics, Inc Oligonucleotide primers for efficient multiplex detection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and methods of use thereof
AU3438999A (en) * 1999-05-07 2000-11-21 Nationales Zentrum Fur Retroviren Detection system for human immunodeficiency virus based on nucleic acid amplification
EP1422298B1 (de) * 1999-07-09 2010-01-27 Gen-Probe Incorporated HIV-1 Detektion mittels Nukleinsäureamplifizierung
DE19950953B4 (de) * 1999-10-23 2004-07-01 Ganser, Arnold, Prof.Dr. Verfahren zur Herstellung lentiviraler Partikel
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
ATE386821T1 (de) 2000-10-23 2008-03-15 Gen Probe Inc Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
US6770752B2 (en) 2001-01-09 2004-08-03 Becton, Dickinson And Company Sequences for detection of HIV-1
US6852491B2 (en) * 2001-09-04 2005-02-08 Abbott Laboratories Amplification and detection reagents for HIV-1
JP2004313181A (ja) * 2003-04-02 2004-11-11 Canon Inc 感染症起炎菌検出用プローブ及びプローブセット、ならびに担体及び遺伝子検査方法
JP4699384B2 (ja) * 2003-12-19 2011-06-08 ジェン−プロウブ インコーポレイテッド Hiv−1およびhiv−2の核酸を検出するための組成物、方法およびキット
US8268982B2 (en) * 2004-01-07 2012-09-18 Hitachi Chemical Co., Ltd. Primers and probes for the detection of HIV
EP1602736A1 (de) 2004-06-04 2005-12-07 Bio-Rad Pasteur Detektion von HIV Typen und Subtypen
EP1627563A1 (de) * 2004-08-10 2006-02-22 Academisch Medisch Centrum bij de Universiteit van Amsterdam Verfahren und Mittel zur Herstellung einer stabilisierten Zelle
PL1794327T3 (pl) 2004-09-14 2017-04-28 Argos Therapeutics, Inc. Niezależna od szczepu amplifikacja patogenów i szczepionki przeciwko nim
EP1647595A1 (de) * 2004-10-15 2006-04-19 Academisch Medisch Centrum bij de Universiteit van Amsterdam Nukleinsäuren gegen Viren, insbesondere gegen HIV
US8383364B2 (en) * 2005-11-17 2013-02-26 Tet Systems Gmbh & Co. Kg Inducible expression systems
USRE49583E1 (en) 2005-11-17 2023-07-18 Tet Systems Gmbh & Co. Kg Inducible expression systems
WO2007067032A1 (en) 2005-12-09 2007-06-14 Academisch Medisch Cemtrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
DK2540820T3 (en) 2005-12-09 2018-03-12 Academisch Medisch Centrum Bij De Univ Van Amsterdam METHODS AND PROCEDURES FOR AFFECTING THE STABILITY OF ANTIBODY-PRODUCING CELLS
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
DE102008025328B4 (de) 2008-05-27 2013-10-17 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von HI-Viren mittels Multiplex-PCR in multiplen Genombereichen
US20100136516A1 (en) * 2008-12-01 2010-06-03 454 Life Sciences Corporation System and method for detection of HIV integrase variants
JP2012510476A (ja) * 2008-12-02 2012-05-10 プロラクタ バイオサイエンス,インコーポレイテッド ヒト乳透過組成物ならびにその製造および使用方法
JP5781508B2 (ja) 2009-07-15 2015-09-24 アイム・セラピューティクス・べー・フェー 高親和性抗体を産生させるための手段および方法
PL2646466T3 (pl) 2010-12-02 2017-09-29 Aimm Therapeutics B.V. Środki i sposoby do wytwarzania przeciwciał o wysokim powinowactwie
EP3099709B1 (de) 2014-01-31 2019-12-25 AIMM Therapeutics B.V. Mittel und verfahren zur herstellung von stabilen antikörpern
ES2800474T3 (es) * 2014-05-27 2020-12-30 Univ Paris Descartes Método in vitro para la detección y la cuantificación del VIH-2
EP3215639B1 (de) * 2014-11-06 2019-05-15 The United States of America, as represented by The Secretary, Department of Health and Human Services Nachweis von hiv-1-nukleinsäuren durch umkehrtranskriptionsschleifenvermittelte isotherme verstärkung
WO2016137975A1 (en) 2015-02-23 2016-09-01 University Of Washington Primers, probes and methods for sensitive, specific detection and monitoring of hiv-1 and hcv
CN104911277B (zh) * 2015-04-14 2018-02-06 广州海力特生物科技有限公司 一种检测干血斑标本中人类免疫缺陷病毒1型的试剂盒及其检测方法
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
WO2019070731A1 (en) * 2017-10-03 2019-04-11 Abbott Molecular Inc. ASSAY FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2917150C2 (de) * 1979-04-27 1981-06-11 Blau Kg Fabrik Fuer Kraftfahrzeugteile, 4018 Langenfeld Verschlußdeckel
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
EP0347365B1 (de) * 1988-06-14 1996-08-28 QIAGEN GmbH HIV-2-Virusvarianten
CA1340748C (en) * 1988-07-13 1999-09-14 Stephen Oroszlan Synthetic hiv protease gene and method for its expression
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
ES2275451T3 (es) * 1989-06-02 2009-02-16 Institut Pasteur Secuencias nucleotidicas procedentes del genoma de los retrovirus del tipo vih-1,vih-2 y siv, y sus aplicaciones especialmente para la amplificacion de los genomas de estos retrovirus y para el diagnostico in vitro de las infecciones debidas a estos virus.
DE69029740T2 (de) * 1989-11-30 1997-07-10 Pharmacia Biotech Ab Neues verfahren zum nachweis einer spezifischen nukleinsäuresequenz in einer zellprobe
IE910081A1 (en) * 1990-01-10 1991-07-17 Chiron Corp The use of DNA-dependent RNA polymerase transcripts as¹reporter molecules for signal amplification in nucleic acid¹hybridization assays
FR2663040B1 (fr) * 1990-06-11 1995-09-15 Bio Merieux Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich.
GB9016973D0 (en) * 1990-08-02 1990-09-19 Medical Res Council Viral growth inhibition
DK0554389T4 (da) * 1990-10-17 2002-11-11 Us Health Molekylære kloner af HIV-1 og anvendelse deraf
GB9125623D0 (en) * 1991-12-02 1992-01-29 Dynal As Cell modification
WO1994023069A1 (en) * 1993-03-26 1994-10-13 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
SG63589A1 (en) * 1993-05-14 1999-03-30 Johnson & Johnson Clin Diag Diagnostic compositions elements methods and test kits for amplification and detection of two or more dna's using primers having matched melting temperatures
US5576176A (en) * 1994-03-03 1996-11-19 The Regents Of The University Of California Marker and an assay for detection and monitoring of human immunodeficiency virus latency and activation
CA2211877A1 (en) * 1995-01-30 1996-08-08 Hybridon, Inc. Human immunodeficiency virus transcription inhibitors and methods of their use
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5795722A (en) * 1997-03-18 1998-08-18 Visible Genetics Inc. Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample

Also Published As

Publication number Publication date
EP0887427A3 (de) 2001-10-17
JP4339427B2 (ja) 2009-10-07
SI0887427T1 (sl) 2006-06-30
EP0887427A2 (de) 1998-12-30
US6001558A (en) 1999-12-14
ES2256920T3 (es) 2006-07-16
ATE315667T1 (de) 2006-02-15
DK0887427T3 (da) 2006-05-15
DE69833160T2 (de) 2006-09-14
EP0887427B1 (de) 2006-01-11
JPH1169987A (ja) 1999-03-16

Similar Documents

Publication Publication Date Title
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
NO20000513L (no) Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav
WO1990015066A3 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
TR199801418T2 (xx) Rekombinant a�� vekt�rleri kar���m�.
DE69627408D1 (de) Primers und Sonden zum Nachweis von HIV
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
DE69804464D1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
ATE386821T1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
DK0404625T3 (da) Oligonukleotidsekvenser til amplifikation af genomer af retrovirus af HIV-2 og SIV-typen samt deres anvendelser til in vitro-diagnose af infektioner forårsaget af disse virus
DE69836395D1 (de) Primern zum Nachweis von HIV-1
CA2195125A1 (en) Difluorostatone antiviral agents
NO20000514L (no) Oligonukleotidprimere for effektiv multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) og metoder for anvendelse derav
DE3877212D1 (de) Antivirale anwendung von alpha-oligonucleotiden.
ATE198602T1 (de) Makrocyclische difluorostatonderivate als antivirale mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition